155 related articles for article (PubMed ID: 26543769)
1. Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients.
Mishima C; Kagara N; Matsui S; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Springerplus; 2015; 4():635. PubMed ID: 26543769
[TBL] [Abstract][Full Text] [Related]
2. Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients.
Matsui S; Kagara N; Mishima C; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Oncol Rep; 2016 Oct; 36(4):2225-35. PubMed ID: 27499429
[TBL] [Abstract][Full Text] [Related]
3. Methylation of NBPF1 as a novel marker for the detection of plasma cell-free DNA of breast cancer patients.
Li D; Li P; Wu J; Yi J; Dou Y; Guo X; Yin Y; Wang D; Ma C; Qiu L
Clin Chim Acta; 2018 Sep; 484():81-86. PubMed ID: 29775621
[TBL] [Abstract][Full Text] [Related]
4. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
5. SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer.
Balgkouranidou I; Chimonidou M; Milaki G; Tsaroucha E; Kakolyris S; Georgoulias V; Lianidou E
Clin Chem Lab Med; 2016 Aug; 54(8):1385-93. PubMed ID: 26741346
[TBL] [Abstract][Full Text] [Related]
6.
Matsui S; Kagara N; Mishima C; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Oncol Lett; 2018 Feb; 15(2):2595-2603. PubMed ID: 29434979
[TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
[TBL] [Abstract][Full Text] [Related]
8. SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer.
Chimonidou M; Strati A; Malamos N; Georgoulias V; Lianidou ES
Clin Chem; 2013 Jan; 59(1):270-9. PubMed ID: 23136251
[TBL] [Abstract][Full Text] [Related]
9. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer.
Chimonidou M; Strati A; Malamos N; Kouneli S; Georgoulias V; Lianidou E
Oncotarget; 2017 Sep; 8(42):72054-72068. PubMed ID: 29069768
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
12. Circulating ctDNA methylation quantification of two DNA methyl transferases in papillary thyroid carcinoma.
Khatami F; Teimoori-Toolabi L; Heshmat R; Nasiri S; Saffar H; Mohammadamoli M; Aghdam MH; Larijani B; Tavangar SM
J Cell Biochem; 2019 Oct; 120(10):17422-17437. PubMed ID: 31127647
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of the THRB gene in tissue and plasma of breast cancer patients.
Ling Y; Xu X; Hao J; Ling X; Du X; Liu X; Zhao X
Cancer Genet Cytogenet; 2010 Jan; 196(2):140-5. PubMed ID: 20082849
[TBL] [Abstract][Full Text] [Related]
14. CST6 promoter methylation in circulating cell-free DNA of breast cancer patients.
Chimonidou M; Tzitzira A; Strati A; Sotiropoulou G; Sfikas C; Malamos N; Georgoulias V; Lianidou E
Clin Biochem; 2013 Feb; 46(3):235-40. PubMed ID: 23006792
[TBL] [Abstract][Full Text] [Related]
15. Impact of
Jezkova E; Zubor P; Kajo K; Grendar M; Dokus K; Adamkov M; Lasabova Z; Plank L; Danko J
Oncol Lett; 2017 Jul; 14(1):758-766. PubMed ID: 28693231
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients.
Heng J; Guo X; Wu W; Wang Y; Li G; Chen M; Peng L; Wang S; Dai L; Tang L; Wang J
PLoS One; 2017; 12(3):e0174022. PubMed ID: 28301567
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer].
Li M; Li O; Sun J; Zheng X; Ma D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Apr; 42(2):164-171. PubMed ID: 32385021
[No Abstract] [Full Text] [Related]
18. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
19.
Londra D; Mastoraki S; Bournakis E; Zavridou M; Thanos A; Rampias T; Lianidou ES
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572834
[TBL] [Abstract][Full Text] [Related]
20. RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.
Giannopoulou L; Chebouti I; Pavlakis K; Kasimir-Bauer S; Lianidou ES
Oncotarget; 2017 Mar; 8(13):21429-21443. PubMed ID: 28206954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
